
Keywords: coronary disease; drug-eluting; imaging; scaffold; stent(s)%DS, percent diameter stenosis; BCS, bioresorbable coronary scaffold; CK, creatine kinase; DES, drug-eluting stent(s); IVUS, intravascular ultrasound; LLL, late lumen loss; MACE, major adverse car